Among the large drugmakers, Eli Lilly, AstraZeneca, Pfizer, Sanofi and Bayer are worth retaining in one’s portfolio.

The drug and biotech industry has done well this year, driven by increased mergers and acquisitions (M&A), the launch of ...

Sanofi last year recorded a combined 10.72 ... Unilever overhauling European homecare supply chain, executive says 3:40 PM UTC · Updated ago Legalcategory US Supreme Court rebuffs Uber, Lyft ...

Sanofi has asked bidders to revise their proposals for its consumer health unit, people with knowledge of the matter said, as it considers whether to seek a sale or listing of the business. The ...

CSL Seqirus, Sanofi and GSK have collectively secured $72 million in funding from the U.S. health department to boost the country’s supply of bird flu vaccines. The grant comes from the ...

“Sanofi is a global leader in immunological ... research and preclinical and clinical testing; disruptions in the supply chain, including raw materials needed for manufacturing and animals ...

Also Read: FDA Approves Regeneron/Sanofi’s Blockbuster Dupixent For Smoker’s Lung Disease. The FDA approved the drug in 2022. Administered as chronic IV treatment. Enjaymo generated ...

The latest award from the government, which includes $37.9 million for CSL, $23.4 million for Sanofi and $10.5 million for GSK, would more than double the United States' supply of shots targeting ...